Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
12,743 datasets
A 45.1 KB document authored by Arushi Gahlot Saini, last updated on 2026-05-04. This review provides a detailed analysis of cobalamin (vitamin B12) metabolism, its associated inborn errors, and their clinical and neurological impacts in the pediatric population.
A single-arm Phase 1 study assessed the safety and preliminary efficacy of a second group retreat psilocybin therapy experience for 13 partial responders with metastatic cancer. The protocol included a higher initial dose, an optional booster, and no antidepressant tapering requirement. Results include safety data, Hospital Anxiety and Depression Scale (HADS) scores, and Mystical Experience Questionnaire (MEQ) outcomes collected up to 24-week follow-up.
Data Sheet 1_A is a PDF document containing results from a single-arm Phase 1 clinical trial. The study, authored by Anthony L. Back and uploaded to figshare in April 2026, assessed the safety and preliminary efficacy of a second group retreat psilocybin therapy experience for 13 partial responders with metastatic cancer. It reports on adverse events, changes in Hospital Anxiety and Depression Scale (HADS) scores, and mystical experience questionnaire results over a 24-week follow-up.
193 Parkinson's disease patients, 80 caregivers, and their attending physicians at Keio University Hospital participated in a cross-sectional study. They independently ranked the three most troublesome symptoms from a comprehensive list and completed questionnaires on motor complications. The dataset, authored by Shohei Okusa and last updated in May 2026, reveals discrepancies in symptom recognition and perceived burden among the three groups.
5,718 patients with irritable bowel syndrome with constipation (IBS-C) from 9 randomized controlled trials are analyzed in this systematic review and meta-analysis. The dataset, authored by Zihao Zhou and last updated in April 2026, compares the efficacy and safety of guanylyl cyclase C agonists (linaclotide and plecanatide) against placebo.
A 2025 systematic review and meta-analysis of 9 randomized controlled trials involving 5,718 patients with irritable bowel syndrome with constipation (IBS-C). The dataset, authored by Zihao Zhou and last updated in April 2026, compares the efficacy and safety of Guanylyl cyclase C agonists (linaclotide and plecanatide) against placebo, using FDA composite endpoints and safety outcomes.
Zihao Zhou's systematic review and meta-analysis, uploaded to figshare on 2026-04-10, evaluates the efficacy and safety of linaclotide and plecanatide for irritable bowel syndrome with constipation. The analysis includes 9 randomized controlled trials involving 5,718 patients, comparing drug treatments against placebo. Results include relative risks for FDA composite endpoints and diarrhea incidence.
A study by Yibo Meng, last updated in April 2026, investigates microRNA-769-5p in endometriosis. Data includes serum samples from 120 patients and 100 healthy controls, with results from RT-qPCR, cell proliferation, migration, and invasion assays. The findings indicate miR-769-5p targets follistatin to inhibit cellular behaviors associated with disease progression.
A controlled ambiguity benchmark for exact CFG/PCFG parsing built for the paper 'Symplectic Inside--Outside Atlas for Ambiguous Grammars'. The dataset is intended for chart-level diagnostics, ambiguity stress tests, weighted deduction experiments, and parser-evaluation studies, illustrating that parse count alone does not determine ambiguity geometry. It was created by Lightcap and was last updated on June 15, 2026.
4.2% overall missingness characterizes this clinical dataset, with no variable exceeding 15% missing data. The CSV file presents percentages of missing values for each variable across an overall cohort and stratified by one-year survival outcome. Alexy Tran-Dinh published the analysis on figshare in May 2026.
A systematic review and meta-analysis from 2026 evaluates the diagnostic efficacy of VELscope for oral potentially malignant disorders. The analysis includes 24 studies retrieved from eight databases, reporting a sensitivity of 84% and specificity of 45%. The supplementary file was authored by Yan Li and is licensed under CC-BY-4.0.
49.7 KB CSV file containing supplemental data from a study on preexisting T-cell receptor clones in patients with head and neck squamous cell carcinoma treated with dual immune checkpoint inhibitors. The dataset, authored by Huaibin Ge and shared under a CC-BY-4.0 license, likely contains differential expression analysis results for T-cell clones associated with major pathologic responses versus non-responders. It was last updated on June 1, 2026.
A 5.7 KB CSV file containing supplemental data for a study on preexisting T-cell receptor clones in head and neck squamous cell carcinoma patients treated with dual immune checkpoint inhibitors. The dataset, authored by Huaibin Ge and shared under a CC-BY-4.0 license, was last updated on June 1, 2026. Its specific contents likely relate to differential gene expression analysis of pre-super clones comparing non-responders post-treatment versus baseline.
Supplementary Table S11 from a study on dual immune checkpoint inhibitors in head and neck squamous cell carcinoma (HNSCC). The dataset, shared by Huaibin Ge on figshare, contains information on preexisting T-cell receptor clones and their association with major pathologic responses. It was last updated on June 1, 2026, and is shared under a CC-BY-4.0 license.
Supplementary Table S12 from the study 'Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors'. The table, titled 'super_clones_mR_post_vs_baseline_DEG_sig', likely contains data on T-cell receptor clones and differentially expressed genes. Authored by Huaibin Ge and shared under a CC-BY-4.0 license on figshare, the dataset was last updated on June 1, 2026.
A supplemental table from a 2026 research publication on head and neck squamous cell carcinoma. The dataset likely contains differentially expressed genes associated with T-cell receptor super clones, comparing non-responder patients post-treatment versus baseline. Authored by Huaibin Ge and shared under a CC-BY-4.0 license.
Supplementary Table S14 from a study on dual immune checkpoint inhibitor therapy for head and neck squamous cell carcinoma. The dataset, shared by Huaibin Ge on figshare, contains gene expression data related to T-cell receptor clones and major pathologic responses. It was last updated on June 1, 2026.
A supplemental table from a study on dual immune checkpoint inhibitor therapy for head and neck squamous cell carcinoma (HNSCC). The dataset, authored by Huaibin Ge and shared under a CC-BY-4.0 license, contains results of differential gene expression analysis comparing pre-existing and new T-cell receptor clones. It is a 442.2 KB CSV file hosted on figshare.
Supplementary Table S16 from a study on T-cell receptor clones in head and neck squamous cell carcinoma patients treated with dual immune checkpoint inhibitors. The dataset, shared by Huaibin Ge on figshare, contains 359.8 KB of data in CSV format. It was last updated on June 1, 2026.
Supplementary Table S17 from a study on preexisting TCR clones driving pathologic responses in head and neck squamous cell carcinoma patients treated with dual immune checkpoint inhibitors. The dataset, shared by Huaibin Ge on figshare under a CC-BY-4.0 license, contains differentially expressed genes analysis for MPR-associated T-cell clones. It was last updated on June 1, 2026.